The global extracorporeal membrane oxygenation machine market is set to experience substantial growth, with sales estimated to reach USD 904.1 million by 2034, up from USD 582.2 million in 2024. This anticipated growth reflects a compound annual growth rate (CAGR) of 4.5% over the forecast period from 2024 to 2034. In 2023, the ECMO market generated revenue of USD 557.1 million, marking a year-over-year increase of 4.6% expected to continue into 2024.
ECMO machines are critical components in life support, offering temporary respiratory and/or cardiac support to patients experiencing severe failure of these vital organs. By utilizing an external circuit, ECMO machines pump blood to a membrane oxygenator outside the body. This process effectively removes carbon dioxide and adds oxygen before reinfusing the blood back into the patient, thereby sustaining life during critical periods.
These advanced devices are versatile and can be employed in a variety of medical settings, including intensive care units, operating rooms, and emergency medical services. ECMO machines are often used as a bridge-to-recovery or transplantation modality, providing essential support during complex procedures or critical phases of treatment.
As the medical community continues to advance its capabilities in life support technologies, the ECMO machine market is expected to thrive, driven by increasing demand for sophisticated solutions in critical care.
Key Takeaways: Extracorporeal Membrane Oxygenation (ECMO) Market
- Global ECMO machine sales are expected to grow from USD 582.2 million in 2024 to USD 904.1 million by 2034, at a CAGR of 4.5%.
- ECMO machines are projected to account for 78.5% of the global market share in 2024.
- Infrastructure services are expected to lead the market with a 45.7% share in 2024.
- The East Asia ECMO market is dominated by China, projected to grow at a CAGR of 4.5%.
- The German ECMO market is expected to grow at a CAGR of 1.4%.
- The US ECMO market is anticipated to grow at a CAGR of 1.4%.
Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!
Competitive Landscape:
The extracorporeal membrane oxygenation (ECMO) machine market is moderately concentrated, with numerous manufacturers globally striving to innovate and meet diverse customer needs. Despite this broad participation, a few major players dominate the market, including Medtronic, Fresenius Medical Care A.G. & Co. KGAA, Getinge Group, and Terumo Cardiovascular Systems Corporation.
Leading ECMO manufacturers are focusing on international expansion to boost revenue and broaden their sales footprint. To advance their product offerings, these companies frequently collaborate with research institutions to develop cutting-edge devices.
Key strategies employed by manufacturers to enhance product sales and market presence include strategic agreements, product launches, research sponsorships, and collaborations.
Recent Industry Developments in the ECMO Machine Market:
- In July 2022, Inspira Technologies Oxy B.H.N. Ltd., a specialized medical device company, introduced the Liby™ System, an advanced ECMO system designed to treat patients with severe heart and lung failure.
- Medtronic, an American-Irish medical device leader, offers a range of ECMO support products, including the Nautilus™ SMART ECMO Module, NAUTILUS™ ECMO Oxygenator, and CRESCENT™ JUGULAR DUAL LUMEN CATHETER. Beyond ECMO devices, Medtronic also provides solutions for cardiac rhythm management, spinal and orthopedic surgery, diabetes management, and gastrointestinal care.
Key Players of Extracorporeal Membrane Oxygenation Machine Industry:
- Medtronic
- Fresenius Medical Care A.G. & Co. KGAA
- Maquet Holding
- Getinge Group
- Microport
- Origin Biomedical
- Terumo Cardiovascular Systems Corporation
- Livanova plc
- Nipro Corporation
- Euro sets S.R.L.
- Cytosorbents Corporation
- Abiomed.
Key Segments of Extracorporeal Membrane Oxygenation Machine Industry:
By Product:
In terms of product, the industry is divided into ECMO machines (portable devices and static devices) and software
By Service Type:
In terms of service type, the industry is segregated into application, middleware, and infrastructure
By Component:
In terms of component, the industry is divided into pumps, oxygenators, controllers, cannula, and accessories.
By Modality:
In terms of modality, the industry is segregated into veno-venous, veno-arterials, and arterio-venous
By Patient Type:
In terms of end user, the industry is segregated into neonates, pediatrics, and adults
By Region:
Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
